Alexandre Avila

2.8k total citations
10 papers, 595 citations indexed

About

Alexandre Avila is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Alexandre Avila has authored 10 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Immunology. Recurrent topics in Alexandre Avila's work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers) and Brain Metastases and Treatment (4 papers). Alexandre Avila is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers) and Brain Metastases and Treatment (4 papers). Alexandre Avila collaborates with scholars based in United States, Brazil and Canada. Alexandre Avila's co-authors include F. Stephen Hodi, Evan J. Lipson, T.J. Williams, John C. Probasco, Dung T. Le, Josep Dalmau, Ellen M. Mowry, Christopher D. Lao, William H. Sharfman and David A. Reardon and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Oncologist.

In The Last Decade

Alexandre Avila

9 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Avila United States 7 471 291 151 128 112 10 595
James Ford United States 4 203 0.4× 119 0.4× 68 0.5× 74 0.6× 206 1.8× 7 617
Helene Cauwel United States 3 183 0.4× 122 0.4× 76 0.5× 79 0.6× 180 1.6× 4 600
Waldemar Och Poland 10 175 0.4× 133 0.5× 118 0.8× 32 0.3× 116 1.0× 27 361
Sigmund Hsu United States 9 116 0.2× 160 0.5× 318 2.1× 55 0.4× 160 1.4× 26 498
Sundeep Deorah United States 7 115 0.2× 202 0.7× 151 1.0× 32 0.3× 114 1.0× 9 508
Curt J. Essenburg United States 9 149 0.3× 106 0.4× 40 0.3× 61 0.5× 180 1.6× 17 413
F. Cardenal Spain 11 337 0.7× 204 0.7× 17 0.1× 222 1.7× 199 1.8× 21 696
Mart A. A. M. Heesters Netherlands 8 97 0.2× 98 0.3× 235 1.6× 61 0.5× 104 0.9× 10 472
Jethro Hu United States 13 93 0.2× 85 0.3× 295 2.0× 51 0.4× 139 1.2× 34 471
Estelle Daudigeos‐Dubus France 11 102 0.2× 89 0.3× 58 0.4× 90 0.7× 161 1.4× 19 332

Countries citing papers authored by Alexandre Avila

Since Specialization
Citations

This map shows the geographic impact of Alexandre Avila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Avila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Avila more than expected).

Fields of papers citing papers by Alexandre Avila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Avila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Avila. The network helps show where Alexandre Avila may publish in the future.

Co-authorship network of co-authors of Alexandre Avila

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Avila. A scholar is included among the top collaborators of Alexandre Avila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Avila. Alexandre Avila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Rapisuwon, Suthee, Benjamin Izar, Cory Batenchuk, et al.. (2019). Exceptional response and multisystem autoimmune-like toxicities associated with the same T cell clone in a patient with uveal melanoma treated with immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. 7(1). 61–61. 36 indexed citations
2.
3.
Hogg, David, Paul B. Chapman, Mario Sznol, et al.. (2017). Overall survival (OS) analysis from an expanded access program (EAP) of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (MEL).. Journal of Clinical Oncology. 35(15_suppl). 9522–9522. 6 indexed citations
4.
Larkin, James, Bartosz Chmielowski, Christopher D. Lao, et al.. (2017). Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis. The Oncologist. 22(6). 709–718. 205 indexed citations
5.
Tawbi, Hussein, Peter Forsyth, Alain P. Algazi, et al.. (2017). Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204.. Journal of Clinical Oncology. 35(15_suppl). 9507–9507. 97 indexed citations
6.
Williams, T.J., Josep Dalmau, Alexandre Avila, et al.. (2016). Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer. JAMA Neurology. 73(8). 928–928. 203 indexed citations
7.
Chapman, Paul B., Mario Sznol, Christopher D. Lao, et al.. (2016). Safety data from an expanded access program (EAP) of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (MEL).. Journal of Clinical Oncology. 34(15_suppl). 9525–9525. 3 indexed citations
8.
9.
Avila, Alexandre, Ana Cristina Victorino Krepischi, Felipe Cavalcanti Carneiro da Silva, et al.. (2014). Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma. Familial Cancer. 13(4). 645–649. 15 indexed citations
10.
Avila, Alexandre, et al.. (2011). Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article. Clinics. 66(3). 493–499. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Ford Breakdown of academic impact, for papers by Helene Cauwel Breakdown of academic impact, for papers by Waldemar Och Breakdown of academic impact, for papers by Sigmund Hsu Breakdown of academic impact, for papers by Sundeep Deorah Breakdown of academic impact, for papers by Curt J. Essenburg Breakdown of academic impact, for papers by F. Cardenal Breakdown of academic impact, for papers by Mart A. A. M. Heesters Breakdown of academic impact, for papers by Jethro Hu Breakdown of academic impact, for papers by Estelle Daudigeos‐Dubus
Rankless by CCL
2026